1. Search Result
Search Result
Isoforms Recommended: TNFRSF12A/TWEAK
Results for "

Fn14

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

3

Inhibitory Antibodies

3

Recombinant Proteins

3

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99361

    PDL192; ABT-361; Anti-TNFRSF12A/TWEAKR/CD266 Reference Antibody (enavatuzumab)

    TNF Receptor Cancer
    Enavatuzumab (PDL192; ABT-361) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab can actively recruits and activates myeloid effectors to kill tumor cells. Enavatuzumab inhibits the growth of various human TweakR-positive cancer cell lines and xenografts in vitro and in vivo .
    Enavatuzumab
  • HY-113763

    TNF Receptor Others
    L524-0366 is a specific, dose-dependent TWEAK-Fn14 inhibitor. L524-0366 specifically binds to the Fn14 surface with a KD of 7.12 μM, competitively inhibiting the binding of Fn14 to TWEAK (inhibition rate reaching 16%). L524-0366 inhibits TWEAK-induced glioma cell migration without potential cytotoxic effects .
    L524-0366
  • HY-122575
    Aurintricarboxylic acid
    3 Publications Verification

    P2X Receptor Influenza Virus Topoisomerase MicroRNA Apoptosis Infection Neurological Disease Inflammation/Immunology
    Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively . Aurintricarboxylic acid is a potent anti-influenza agent by directly inhibiting the neuraminidase . Aurintricarboxylic acid is an inhibitor of topoisomerase II and apoptosis . Aurintricarboxylic acid is a selective inhibitor of the TWEAK-Fn14 signaling pathway . Aurintricarboxylic acid also acts as a cystathionine-lyase (CSE) inhibitor with an IC50 of 0.6 μM . Aurintricarboxylic acid is a modifier of miRNAs that regulate miRNA function, with an IC50 of 0.47 µM .
    Aurintricarboxylic acid
  • HY-P991433

    TNF Receptor Cancer
    BIIB036 is a human IgG1 monoclonal antibody (mAb) targeting TNFRSF12A/Fn14. BIIB036 inhibits the growth of patient-derived primary colorectal tumors in SCID mice .
    BIIB036
  • HY-RS14803

    Small Interfering RNA (siRNA) Others

    TNFRSF12A Human Pre-designed siRNA Set A contains three designed siRNAs for TNFRSF12A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    TNFRSF12A Human Pre-designed siRNA Set A
    TNFRSF12A Human Pre-designed siRNA Set A
  • HY-RS17480

    Small Interfering RNA (siRNA) Others

    Tnfrsf12a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tnfrsf12a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Tnfrsf12a Mouse Pre-designed siRNA Set A
    Tnfrsf12a Mouse Pre-designed siRNA Set A
  • HY-RS23938

    Small Interfering RNA (siRNA) Others

    Tnfrsf12a Rat Pre-designed siRNA Set A contains three designed siRNAs for Tnfrsf12a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Tnfrsf12a Rat Pre-designed siRNA Set A
    Tnfrsf12a Rat Pre-designed siRNA Set A
  • HY-P992321

    TNF Receptor NF-κB STAT Cancer
    BAY-356, a potent TWEAK receptor agonist, is an aglycosylated anti-TWEAK receptor antibody. BAY-356 triggers TWEAKR hyperactivation, activates NFκB and STAT1 pathways, and undergoes TWEAKR-dependent internalization. BAY-356 can be used for the research of colorectal cancer, bladder cancer, non-small cell lung cancer and pancreatic cancer[1][2].
    BAY-356

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: